KIDS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
OrthoPediatrics Corp (KIDS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong revenue growth, improving gross margins, and a positive outlook in the pediatric orthopedics market. While profitability challenges exist, the recent positive free cash flow and analysts' bullish ratings with upside potential make it a compelling long-term investment.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the stock is trading below key moving averages (SMA_200 > SMA_20 > SMA_5), which suggests a bearish trend in the short term. Support is at 16.004, and resistance is at 17.639, with the stock currently trading near resistance levels.
Hedge funds are significantly increasing their positions in the stock.
Analysts have initiated coverage with Buy ratings and price targets of $23-$24, citing strong market leadership and growth potential.
The company achieved its first positive free cash flow of $10 million in Q4
Revenue grew 17% YoY in Q4 2025, with a strong gross margin of 73.22%.
EPS missed expectations in Q4 2025, with a YoY decline of 37.68%.
The stock is trading below key moving averages, indicating bearish momentum in the short term.
Post-market price change of -0.73% suggests some negative sentiment.
In Q4 2025, revenue increased by 16.97% YoY to $61.6 million, and gross margin improved to 73.22%. However, net income dropped by 37.13% YoY to -$10.1 million, and EPS declined by 37.68% to -$0.43. Despite profitability challenges, the company achieved its first positive free cash flow of $10 million.
Analysts are bullish on the stock, with TD Cowen and Canaccord initiating Buy ratings and price targets of $23-$24. They highlight OrthoPediatrics' leadership in the pediatric orthopedics market and its potential for sustained revenue growth, improving EBITDA, and free cash flow breakeven.
